(Q43918015)

28 November 2017

title

Broth microdilution and E-test for determining fluoroquinolone activity against Streptococcus pneumoniae (English)

1 reference

28 November 2017

main subject

Streptococcus pneumoniae

1 reference

Michael B Kays

1

1 reference

28 November 2017

Melissa A Graff

series ordinal

2

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Annals of Pharmacotherapy

28 November 2017

published in

1 reference

28 November 2017

volume

36

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

416-422

1 reference

Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae

28 November 2017

cites work

1 reference

Activity of CP99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci

21 January 2018

1 reference

Antipneumococcal activities of gemifloxacin compared to those of nine other agents

21 January 2018

1 reference

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

Premarketing population pharmacokinetic study of levofloxacin in normal subjects and patients with infectious diseases

21 January 2018

1 reference

Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans

21 January 2018

1 reference

Safety and pharmacokinetics of a single oral dose of gatifloxacin in patients with moderate to severe hepatic impairment.

21 January 2018

1 reference

A dose-escalation study of the safety, tolerability, and pharmacokinetics of intravenous gatifloxacin in healthy adult men.

21 January 2018

1 reference

Interchangeability of 400-mg intravenous and oral gatifloxacin in healthy adults.

21 January 2018

1 reference

Effect of Maalox on the bioavailability of oral gemifloxacin in healthy volunteers

21 January 2018

1 reference

Pharmacokinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers

21 January 2018

1 reference

In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri.

21 January 2018

1 reference

Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A119

1 reference

28 November 2017

1 reference